← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 18, 2021Last known activity
Jan 31, 2025
Acquired by Biomarin on May 16, 2025
Timeline
2010s
- Jun 1, 2015
Inozyme Pharma— Founded
2020s
- May 16, 2025
Biomarin— Acquired By
Drugs by trial phase (1 distinct, 7 trials)
Phase 3 (1 own, 0 via acquisition)
Recent trials (14)
- NCT06739980Lead sponsorPhase 2Jan 31, 2025
- NCT06739980OfficialPhase 2Jan 31, 2025
- NCT06462547Lead sponsorPhase 2Jun 19, 2024
- NCT06462547OfficialPhase 2Jun 19, 2024
- NCT06283589OfficialPhase 1Feb 12, 2024
- NCT06283589Lead sponsorPhase 1Feb 12, 2024
- NCT06046820Lead sponsorPhase 3Jan 12, 2024
- NCT06046820Study directorPhase 3Jan 12, 2024
- NCT05734196Lead sponsorPhase 1May 25, 2023
- NCT05734196Study directorPhase 1May 25, 2023
- NCT05030831Lead sponsorPhase 1/Phase 2Sep 22, 2021
- NCT05030831Study directorPhase 1/Phase 2Sep 22, 2021
- NCT04686175Lead sponsorPhase 1/Phase 2Jun 18, 2021
- NCT04686175Study directorPhase 1/Phase 2Jun 18, 2021
Details
- Founded
- Boston, MA, US Jun 1, 2015
- Last known activity
- Jan 31, 2025